EUVIMEDDescoperă EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review

Mathilde Kamp Nørlund iD, Louise Lehmann Christensen iD, Marianne Skovsager Andersen, Tine Taulbjerg Kristensen, Jan Frystyk, Jonas Mathiesen, Jakob Lindberg Nielsen, Dorte Glintborg iD

Andrology · 2026-01 · 14 (1) · 303-321

DOI: 10.1111/andr.70058 ↗

At a glance

Systematische Übersicht in Andrology, published online on 2025-05-16. Written by Mathilde Kamp Nørlund and 7 co-authors. Institution: Faculty of Health Sciences, Clinical Institute, University of Southern Denmark, Odense, Denmark. Major MEDLINE topics: Muscle Strength, Exercise, Transsexualism, Hormone Replacement Therapy. Cited 4 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: OUH Pre-graduate Fund, Odense University Hospital, Region of Southern Denmark.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Higher muscle strength is associated with improved overall health and lower mortality. Muscle strength changes during gender‐affirming hormone therapy is possibly linked to gender‐affirming hormone therapy modality, age at initiation, gender‐affirming hormone therapy duration, and physical activity.

Aim

To review published literature on muscle strength changes during gender‐affirming hormone therapy.

Methods

Studies were included if they met the PICOS criteria; P: transgender individuals ≥18 years, I: gender‐affirming hormone therapy, C: gender‐affirming hormone therapy‐naïve transgender persons or cisgender controls, O: muscle strength and physical activity in relation to muscle strength, S: prospective cohorts or cross‐sectional.

Results

Fifteen studies with data on 1206 transgender persons (722 transmasculine persons, median age 23–37 years and 484 transfeminine persons, median age 27–41 years) were included. Prospective design was used in eight out of 15 studies (two out of eight on transmasculine, two out of eight on transfeminine, and four out of eight on both) and seven out of 15 were cross‐sectional (two out of seven on transmasculine, four out of seven on transfeminine, and one out of seven on both). Isometric elbow flexion/extension, lower body strength, and handgrip strength were assessed in one out of 15 studies, four out of 15, and 12 out of 15 studies, respectively. Bias rating was moderate to high. Prospective studies Masculinizing gender‐affirming hormone therapy resulted in increased (four out of six studies) or unchanged (two out of six studies) muscle strength, while feminizing gender‐affirming hormone therapy resulted in decreased (three out of six studies) or unchanged (three out of six studies) muscle strength. Muscle strength changes mainly occurred during the first year after initiating gender‐affirming hormone therapy and age at initiation had no impact. Cross‐sectional studies Transmasculine and transfeminine persons had higher strength compared with cisgender women, but lower strength than cisgender men. Physical activity was unchanged during gender‐affirming hormone therapy in five out of prospective studies, while transfeminine persons were less physically active than cisgender men in five out of five prospective studies.

Conclusion

Muscle strength appeared to increase during masculinizing gender‐affirming hormone therapy and decrease during feminizing gender‐affirming hormone therapy, whereas physical activity was unchanged. Given high risk of bias, more research is necessary. Improving transgender care requires engagement of transgender persons in physical activity.

Subjects

MeSH terms (MEDLINE)

Muscle StrengthExerciseTranssexualismHormone Replacement TherapyHumansMaleFemaleTransgender PersonsAdultCross-Sectional StudiesYoung Adult

Author keywords

gender‐affirming hormone therapymuscle strengthphysical activitytransgender

Authors and institutions

  • Faculty of Health Sciences, Clinical Institute, University of Southern Denmark, Odense, Denmark.
  • Department of Endocrinology, Odense University Hospital, Odense, Denmark.
  • Department of Sports Science and Clinical Biomechanics, Muscle Physiology and Biomechanics Research Unit, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Research, Geriatric Research Unit, University of Southern Denmark, Odense, Denmark.

ORCID profiles: Mathilde Kamp Nørlund, Louise Lehmann Christensen, Dorte Glintborg

Funding

  • OUH Pre-graduate Fund
  • Odense University Hospital
  • Region of Southern Denmark
  • Danish Research Council, Region of Southern Denmark
  • The Danish Health Authority
  • Novo Nordisk Foundation
  • The Danish Diabetes and Endocrine Academy
  • BIC (Body Identity Clinic) Frontline Center

Cite

APA

Nørlund, M. K., Christensen, L. L., Andersen, M. S., Kristensen, T. T., Frystyk, J., Mathiesen, J., Nielsen, J. L., & Glintborg, D. (2026). Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review. Andrology, 14(1), 303-321. https://doi.org/10.1111/andr.70058

Vancouver

Nørlund MK, Christensen LL, Andersen MS, Kristensen TT, Frystyk J, Mathiesen J, et al. Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review. Andrology. 2026;14(1):303-321. doi:10.1111/andr.70058

BibTeX
@article{Nrlund2026,
  author = {Nørlund, Mathilde Kamp and Christensen, Louise Lehmann and Andersen, Marianne Skovsager and Kristensen, Tine Taulbjerg and Frystyk, Jan and Mathiesen, Jonas and Nielsen, Jakob Lindberg and Glintborg, Dorte},
  title = {Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review},
  journal = {Andrology},
  year = {2026},
  volume = {14},
  number = {1},
  pages = {303--321},
  doi = {10.1111/andr.70058}
}
Start for free →